Tokyo IPO

Japanese

Modalis Therapeutics Corporation

Code Sector Market
4883 Pharmaceuticals MTH
Date of listing approval 2020/06/26
Expected Date 2020/08/03
Lead Underwriter Mizuho    
Description Research and development of gene therapy drugs using the core platform technology "Incisive CRISPR technology (CRISPR-GNDM technology)"
Listed Shares(total) 3,105,000
Trading Unit 100
New Shares 2,100,000
Existing Shares 1,005,000° incl. O.A.°ň
Shares Outstanding PreIPO 25,100,000.00
PostIPO 27,200,000.00
Paid Up Capital PreIPO Y1,300,000,000
PostIPO Y2,075,008,000
Expected Pricing Date 2020/07/10
Book Building Start 2020/07/14
Book Building End 2020/07/20
Fix Date 2020/07/21
Offering Starts 2020/07/22
Offering Ends 2020/07/29
Expect Pricing Y1,000-Y1,200
Notional PER
(based on previous period)
167.79-201.34
Offering Price Y1,200
Offering Price PER
(based on previous period)
 - 
Offering Price PBR
(based on previous period)
7.84
Use of Funds Raised  

Financial Data

Units:Y1,000

Fiscal Year End:2017/12
Consolidated Non-consolidated
Revenue - 17,921
Current Profit - -141,200
Net Profit - -142,150
Net Assets - 1,421,735
Fiscal Year End:2018/12
Consolidated Non-consolidated
Revenue 65,297 65,297
Current Profit -213,390 -228,981
Net Profit -217,909 -229,932
Net Assets 1,201,779 1,191,802
Fiscal Year End:2019/12
Consolidated Non-consolidated
Revenue 644,500 644,500
Current Profit 146,351 128,822
Net Profit 140,528 127,899
Net Assets 3,842,542 3,819,701
Recent Quarter
2020/03
Consolidated Non-consolidated
Revenue 13,000 -
Current Profit -116,924 -
Net Profit -118,286 -
Net Assets 3,724,455 -

Per Share Units:Y1

Fiscal Year End:2017/12
Consolidated Non-consolidated
Dividend 0.00
Net Earning - -
Equity -10.29 -3.89
Fiscal Year End:2018/12
Consolidated Non-consolidated
Dividend 0.00
Net Earning -10.84 -14.84
Equity -11.44 -15.33
Fiscal Year End:2019/12
Consolidated Non-consolidated
Dividend 0.00
Net Earning 5.96 153.09
Equity 5.43 152.18
Fiscal Year End:Recent Quarter
2020/03
Consolidated Non-consolidated
Dividend
Net Earning -4.71 -
Equity - -

Comment

Ę£Over allotment(405,000)

Consolidated Subsidiaries

Name Address

Underwriters

Allocation Underwriter Tel
0% Nomura 03-3211-1811
75% Mizuho 03-5208-3210
11% SBI SECURITIES Co.,Ltd. 03-5562-7210
11% SMBC Nikko 03-5644-3111
1.5% Ichiyoshi 03-3555-6210
1.5% Ace 06-6267-2111

Data

Date of incorporation 2016/01/14
Company address  Tokyo 103-0026
Telephone 03-6822-4584
President  
Homepage https://www.modalistx.com/jp/
Auditor Azsa
Major Shareholders
Shareholder Name Ratio
86.62%
  17.86%
  16.07%
  8.39%
  8.39%
  3.75%
  3.57%
  2.86%
  2.68%
  2.68%
  2.59%
Number of Employees 3 as of 2020/05/31
Birth Date of Representative 1969/08/09

Comment